Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.

Autor: F, Dominguez M, I, Macias R, I, Izco-Basurko, A, de La Fuente, J, Pascual M, M, Criado J, J, Monte M, J, Yajeya, J, Marin J

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; June 2001, Vol. 297 Issue: 3 p1106-12, 7p